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Background
We presented our management of all CSF shunt infections
and their prevention in 2000 and 2007. This paper
describes our experience with treatment of shunt infec-
tions with and without surgery.
Materials and methods
We describe analysis of data stored in two computer data-
bases for 2,193 shunt related operations involving 786
patients. Infections were defined as positive cultures of the
CSF or the shunt. Antibiotic levels in the CSF and Mini-
mam Bacteriocidal (MBC) levels are expressed in ug/ml.
Operative procedures were complete shunt removal,
placement of an extra ventricular drain, antibiotics until
the CSF was sterile, then replacement of the shunt
((CSR+EVD+abx+R), externalization of the distal limb,
abx, then R (Ex+abx+R) and antibiotics alone. Analysis
was by transfer to Excel files, Fisher Exact and Student t-
tests. A cure was defined as 16 months without recurrent
infection or a new infection with another organism.
Results
Six infections followed 65 operations not shunt related
(9%), 17 after 131 complex shunt operations (13%), and
54 after 1024 revisions and 32 after 607 insertions (5%
each) with only the rate after complex shunt operation
significantly higher (X = 9.1, df = 1, P = 0.0025). Fifty-
three patients experienced 55 infections and 67 trials of
treatment for Coagulase Negative Staphylococcal (S CoN)
infections (14 had 2 trials). Equivalent cure rates were
recorded for treatment of S Co N infections without sur-
gery (23/26 – 88%) and with CSR+EVD+abx+R (29/30 –
97%) P = 0.3; but both were more effective than Ex+abx+R
(2/11 – 18%) P < 0.000. Of 14 infections due to other
"treatable" organisms usually associated with meningitis,
9 without surgery (64%) and 5 with surgery were cured on
the first trial. Shunt operations ranged from 48 to 204 per
year and did not vary significantly (t = -1.9, df = 20, P =
0.29) The 123 types of organisms will be listed. The site of
recovery of S CoN, presence of WBC in the CSF and the
degree of S CoN susceptibility did not affect the cure rates.
Hospital days in USA $ in 2006 = $106,433 with surgery
and $43,560 without.
Conclusion
Medical treatment should be tried for 3 days with shunt
infection in the presence of a functioning shunt until the
organism and its sensitivity to levels of antibiotics that can
be safely achieved in the CSF can be identified. SCoN and
bacteria usually associated with meningitis are the only
ones to deserve a medical trial.
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